US
US Glaucoma Surgery Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Procedure, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $658.8 Mn.
Canada at 8.8% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$572.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $614.6 Mn | — | — |
| 2025 (base) | $658.8 Mn | +$44.2 Mn | — |
| 2026 (forecast) | $706.3 Mn | +$47.4 Mn | +7.2% |
| 2027 (forecast) | $757.1 Mn | +$50.9 Mn | +14.9% |
| 2028 (forecast) | $811.6 Mn | +$54.5 Mn | +23.2% |
| 2029 (forecast) | $870.1 Mn | +$58.4 Mn | +32.1% |
| 2030 (forecast) | $932.7 Mn | +$62.6 Mn | +41.6% |
| 2031 (forecast) | $999.9 Mn | +$67.2 Mn | +51.8% |
| 2032 (forecast) | $1.07 Bn | +$72.0 Mn | +62.7% |
| 2033 (forecast) | $1.15 Bn | +$77.2 Mn | +74.4% |
| 2034 (forecast) | $1.23 Bn | +$82.7 Mn | +87% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$658.8 Mn
China
$132.6 Mn
Canada
$126.1 Mn
Japan
$82.3 Mn
Germany
$53.1 Mn
France
$41.9 Mn
Brazil
$39.6 Mn
Italy
$35.8 Mn
UK
$32.6 Mn
Ecuador
$29.6 Mn
India
$28.8 Mn
Spain
$26.4 Mn
Saudi Arabia
$22.9 Mn
Mexico
$19.0 Mn
Russia
$16.0 Mn
Australia
$15.2 Mn
New Zealand
$12.2 Mn
South Africa
$8.4 Mn
UAE
$8.0 Mn
Egypt
$3.8 Mn
Philippines
$3.2 Mn
Hong Kong
$2.5 Mn
Malaysia
$2.3 Mn
Thailand
$1.9 Mn
Singapore
$1.7 Mn
Kenya
$1.0 Mn
Glaucoma surgery devices lower eye pressure using tiny stents, shunts and lasers, often during cataract surgery.
Key segments of the glaucoma Surgery Devices market include product (MIGS Devices, Glaucoma Drainage Devices and Laser Systems) and procedure (Standalone and Combined with Cataract Surgery).
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the glaucoma Surgery Devices market.
Longer-acting treatments, home-based care and screening in emerging markets give the glaucoma Surgery Devices market room to grow.
High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the glaucoma Surgery Devices market.
The glaucoma Surgery Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how glaucoma Surgery Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Glaucoma Surgery Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
US · 1 shared keyword
US · 1 shared keyword
US
US
US
US
Digital Health · US
Pharmaceuticals · US
Pharmaceuticals · US
OTC & Nutraceuticals · US
Pharmaceuticals · US
OTC & Nutraceuticals · US